Adolescent Eczema and Depression Burden Mapped Across 204 Countries
Updated

A study covering 204 countries and territories has quantified how often atopic dermatitis and depressive disorders co-occur in adolescents — and which risk factors track with that overlap. The work appears in the Journal of Investigative Dermatology, Volume 146, Issue 10, Supplement, published October 2026.
The analysis, authored by Shitong Rao, Shuomin Sun, Hongpeng Sun, Danqi Li and Juan Tao, examines disease burden patterns between atopic dermatitis and depressive disorders among adolescents at a global scale. Its appearance in a JID supplement signals that the authors presented the findings at a major dermatology research meeting, with the supplement serving as the citable record of that work.
Why the co-occurrence question matters
Atopic dermatitis is one of the most common inflammatory skin conditions of adolescence, and clinicians have long observed that mood disorders travel with it. What has been harder to establish is the scale of that overlap — and whether the pattern holds uniformly or shifts by region and risk profile.
By pulling data across all 204 countries and territories, the study frames the problem at population level rather than clinic-by-clinic. That design lets the authors compare burden patterns geographically and identify associated risk factors, rather than relying on single-center cohorts that may not generalize.
What does this change for dermatologists?
For practicing dermatologists, the practical takeaway is the reminder that adolescent AD management isn't only about skin scores. If co-occurrence patterns and risk factors are mapped globally, clinicians have a stronger evidence base for screening mood symptoms in teens presenting with eczema — and for anticipating which patients carry the highest combined burden.
The supplement format means full methodological detail — burden metrics, effect estimates, country-level breakdowns — sits in the Journal of Investigative Dermatology, Volume 146, Issue 10, published in October 2026. Readers wanting the specific figures per country or territory will find them there.
With adolescent mental health drawing increasing policy attention, a global map tying depressive disorder burden to atopic dermatitis gives dermatology a concrete anchor for integrated care conversations in the year ahead.
Source: Journal of Investigative Dermatology (Elsevier)
Olivia Hart
Show full bio
News editor covering technology and product news in Clinical dermatology, inflammatory skin disease and biologics at Derm Field.